Rank | Gene Set | Z-score |
---|---|---|
1 | omega-hydroxylase P450 pathway (GO:0097267) | 8.57498560 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.73341665 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.73341665 |
4 | L-phenylalanine metabolic process (GO:0006558) | 7.37756568 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.37756568 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 6.95115155 |
7 | indole-containing compound catabolic process (GO:0042436) | 6.24388771 |
8 | indolalkylamine catabolic process (GO:0046218) | 6.24388771 |
9 | tryptophan catabolic process (GO:0006569) | 6.24388771 |
10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.21373829 |
11 | kynurenine metabolic process (GO:0070189) | 6.10007567 |
12 | bile acid biosynthetic process (GO:0006699) | 5.96449826 |
13 | tryptophan metabolic process (GO:0006568) | 5.87086421 |
14 | urea cycle (GO:0000050) | 5.75592735 |
15 | urea metabolic process (GO:0019627) | 5.75592735 |
16 | glyoxylate metabolic process (GO:0046487) | 5.62734687 |
17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.54443779 |
18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.52013483 |
19 | negative regulation of fibrinolysis (GO:0051918) | 5.47672905 |
20 | protein carboxylation (GO:0018214) | 5.35589347 |
21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.35589347 |
22 | regulation of fibrinolysis (GO:0051917) | 5.30992242 |
23 | nitrogen cycle metabolic process (GO:0071941) | 5.29203598 |
24 | oxidative demethylation (GO:0070989) | 5.23844483 |
25 | sulfur amino acid catabolic process (GO:0000098) | 5.22327156 |
26 | complement activation, alternative pathway (GO:0006957) | 5.20687391 |
27 | cysteine metabolic process (GO:0006534) | 5.20324937 |
28 | regulation of protein activation cascade (GO:2000257) | 5.17176505 |
29 | bile acid metabolic process (GO:0008206) | 5.13177032 |
30 | serine family amino acid catabolic process (GO:0009071) | 5.09216860 |
31 | aromatic amino acid family metabolic process (GO:0009072) | 5.05930913 |
32 | ethanol metabolic process (GO:0006067) | 4.98947099 |
33 | tyrosine metabolic process (GO:0006570) | 4.90590142 |
34 | regulation of cholesterol esterification (GO:0010872) | 4.84238142 |
35 | regulation of complement activation (GO:0030449) | 4.84204883 |
36 | homocysteine metabolic process (GO:0050667) | 4.81538118 |
37 | phenylpropanoid metabolic process (GO:0009698) | 4.79668937 |
38 | reverse cholesterol transport (GO:0043691) | 4.73624312 |
39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.73140422 |
40 | alpha-amino acid catabolic process (GO:1901606) | 4.72958404 |
41 | regulation of triglyceride catabolic process (GO:0010896) | 4.72534630 |
42 | protein-lipid complex remodeling (GO:0034368) | 4.69222507 |
43 | macromolecular complex remodeling (GO:0034367) | 4.69222507 |
44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.69222507 |
45 | lysine catabolic process (GO:0006554) | 4.66612379 |
46 | lysine metabolic process (GO:0006553) | 4.66612379 |
47 | negative regulation of sterol transport (GO:0032372) | 4.66065568 |
48 | negative regulation of cholesterol transport (GO:0032375) | 4.66065568 |
49 | amino-acid betaine metabolic process (GO:0006577) | 4.60489361 |
50 | acylglycerol homeostasis (GO:0055090) | 4.53922954 |
51 | triglyceride homeostasis (GO:0070328) | 4.53922954 |
52 | S-adenosylmethionine metabolic process (GO:0046500) | 4.53364029 |
53 | phospholipid efflux (GO:0033700) | 4.48022295 |
54 | coenzyme catabolic process (GO:0009109) | 4.45939621 |
55 | indolalkylamine metabolic process (GO:0006586) | 4.45551241 |
56 | drug catabolic process (GO:0042737) | 4.42481264 |
57 | cellular ketone body metabolic process (GO:0046950) | 4.40157146 |
58 | cellular glucuronidation (GO:0052695) | 4.40049079 |
59 | bile acid and bile salt transport (GO:0015721) | 4.39476485 |
60 | imidazole-containing compound metabolic process (GO:0052803) | 4.35756280 |
61 | cellular biogenic amine catabolic process (GO:0042402) | 4.34070310 |
62 | amine catabolic process (GO:0009310) | 4.34070310 |
63 | cellular amino acid catabolic process (GO:0009063) | 4.33788613 |
64 | glutamate metabolic process (GO:0006536) | 4.30783947 |
65 | glycine metabolic process (GO:0006544) | 4.28929963 |
66 | plasma lipoprotein particle clearance (GO:0034381) | 4.28421028 |
67 | negative regulation of protein activation cascade (GO:2000258) | 4.22118521 |
68 | benzene-containing compound metabolic process (GO:0042537) | 4.21688002 |
69 | cholesterol efflux (GO:0033344) | 4.20645317 |
70 | serine family amino acid metabolic process (GO:0009069) | 4.10728590 |
71 | cellular modified amino acid catabolic process (GO:0042219) | 4.10424252 |
72 | arginine metabolic process (GO:0006525) | 4.08654394 |
73 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.07554509 |
74 | ethanol oxidation (GO:0006069) | 4.04165252 |
75 | epoxygenase P450 pathway (GO:0019373) | 3.99177283 |
76 | exogenous drug catabolic process (GO:0042738) | 3.98480109 |
77 | regulation of bile acid biosynthetic process (GO:0070857) | 3.95767305 |
78 | aldehyde catabolic process (GO:0046185) | 3.94178538 |
79 | low-density lipoprotein particle remodeling (GO:0034374) | 3.93218747 |
80 | fibrinolysis (GO:0042730) | 3.92322672 |
81 | alkaloid metabolic process (GO:0009820) | 3.92027175 |
82 | uronic acid metabolic process (GO:0006063) | 3.90927532 |
83 | glucuronate metabolic process (GO:0019585) | 3.90927532 |
84 | plasma lipoprotein particle assembly (GO:0034377) | 3.90732723 |
85 | serine family amino acid biosynthetic process (GO:0009070) | 3.89472247 |
86 | negative regulation of complement activation (GO:0045916) | 3.87790898 |
87 | cofactor catabolic process (GO:0051187) | 3.84695904 |
88 | negative regulation of lipase activity (GO:0060192) | 3.81203493 |
89 | flavonoid metabolic process (GO:0009812) | 3.81007627 |
90 | ketone body metabolic process (GO:1902224) | 3.80989339 |
91 | L-methionine salvage (GO:0071267) | 3.78790112 |
92 | L-methionine biosynthetic process (GO:0071265) | 3.78790112 |
93 | amino acid salvage (GO:0043102) | 3.78790112 |
94 | blood coagulation, intrinsic pathway (GO:0007597) | 3.77113067 |
95 | carboxylic acid catabolic process (GO:0046395) | 3.76961227 |
96 | organic acid catabolic process (GO:0016054) | 3.76961227 |
97 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.76858913 |
98 | positive regulation of lipid catabolic process (GO:0050996) | 3.76791534 |
99 | short-chain fatty acid metabolic process (GO:0046459) | 3.76638604 |
100 | regulation of plasminogen activation (GO:0010755) | 3.75793200 |
101 | cholesterol homeostasis (GO:0042632) | 3.71976786 |
102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.71168381 |
103 | acetyl-CoA metabolic process (GO:0006084) | 3.70575739 |
104 | drug metabolic process (GO:0017144) | 3.69279519 |
105 | complement activation, classical pathway (GO:0006958) | 3.68501767 |
106 | phospholipid homeostasis (GO:0055091) | 3.68429480 |
107 | complement activation (GO:0006956) | 3.66948143 |
108 | sterol homeostasis (GO:0055092) | 3.65940454 |
109 | protein activation cascade (GO:0072376) | 3.64364722 |
110 | NAD biosynthetic process (GO:0009435) | 3.60608333 |
111 | regulation of cholesterol homeostasis (GO:2000188) | 3.59488024 |
112 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59107204 |
113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59107204 |
114 | sodium-independent organic anion transport (GO:0043252) | 3.54086958 |
115 | regulation of humoral immune response (GO:0002920) | 3.43907696 |
116 | nucleobase catabolic process (GO:0046113) | 3.36872455 |
117 | negative regulation of blood coagulation (GO:0030195) | 3.26617967 |
118 | negative regulation of hemostasis (GO:1900047) | 3.26617967 |
119 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.22575813 |
120 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.22575813 |
121 | dicarboxylic acid catabolic process (GO:0043649) | 3.17341787 |
122 | opsonization (GO:0008228) | 3.16260937 |
123 | xenobiotic catabolic process (GO:0042178) | 3.16229150 |
124 | gamma-aminobutyric acid transport (GO:0015812) | 3.15964727 |
125 | xenobiotic metabolic process (GO:0006805) | 3.12849441 |
126 | indole-containing compound metabolic process (GO:0042430) | 3.08364535 |
127 | C4-dicarboxylate transport (GO:0015740) | 3.04176972 |
128 | methionine metabolic process (GO:0006555) | 3.03649415 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.33719065 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.08240834 |
3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.86508235 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.47017172 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.36598281 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.97662789 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.73475291 |
8 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.10620169 |
9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97687786 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89400216 |
11 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.88697994 |
12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.28854621 |
13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.22786684 |
14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10459920 |
15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10189755 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8475731 |
17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.97788051 |
18 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97611931 |
19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91817862 |
20 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.91028860 |
21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90758040 |
22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.86555354 |
23 | VDR_22108803_ChIP-Seq_LS180_Human | 1.83279653 |
24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78560339 |
25 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.78120153 |
26 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77274248 |
27 | STAT3_23295773_ChIP-Seq_U87_Human | 1.75052634 |
28 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.71585242 |
29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.70715659 |
30 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.63811487 |
31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.63484487 |
32 | TCF4_23295773_ChIP-Seq_U87_Human | 1.62773661 |
33 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61005468 |
34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60258393 |
35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.55708017 |
36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.52118043 |
37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52099302 |
38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51058000 |
39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50032857 |
40 | AR_25329375_ChIP-Seq_VCAP_Human | 1.49756939 |
41 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47043232 |
42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44904868 |
43 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40581257 |
44 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.40581257 |
45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38899115 |
46 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.38686966 |
47 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38615142 |
48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36095424 |
49 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.35274255 |
50 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.35274255 |
51 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34412874 |
52 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32675288 |
53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31795624 |
54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27720624 |
55 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.26373246 |
56 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.25409240 |
57 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24379030 |
58 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.22842477 |
59 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21149266 |
60 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21149266 |
61 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18729069 |
62 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16133142 |
63 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14773288 |
64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14648303 |
65 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.13016837 |
66 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.11063412 |
67 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08480186 |
68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07299267 |
69 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07123677 |
70 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.06672399 |
71 | EWS_26573619_Chip-Seq_HEK293_Human | 1.06615091 |
72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06409544 |
73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06129614 |
74 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05888771 |
75 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04636375 |
76 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04579797 |
77 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04361483 |
78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04179166 |
79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03584968 |
80 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02542335 |
81 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02144697 |
82 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02106038 |
83 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01979066 |
84 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01269743 |
85 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01251822 |
86 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00931033 |
87 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00745337 |
88 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.00637824 |
89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00125339 |
90 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98558953 |
91 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.95021459 |
92 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93993095 |
93 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93852907 |
94 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.93779052 |
95 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93704599 |
96 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.93304519 |
97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.93304519 |
98 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92839782 |
99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92822043 |
100 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89387698 |
101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88284728 |
102 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86901674 |
103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85064383 |
104 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81905011 |
105 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81471508 |
106 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.81263344 |
107 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77301822 |
108 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76504685 |
109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.74901055 |
110 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74753935 |
111 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74496727 |
112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72261668 |
113 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71380384 |
114 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71029821 |
115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69399371 |
116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69399371 |
117 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.68521773 |
118 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68505395 |
119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67845288 |
120 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.66656898 |
121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66025583 |
122 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65798289 |
123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65261190 |
124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61715724 |
125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61500374 |
126 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.60785956 |
127 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59226688 |
128 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58822274 |
129 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56479231 |
130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55784228 |
131 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55158497 |
132 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.54167745 |
133 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.53918823 |
134 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.53195383 |
135 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53094845 |
136 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53034715 |
137 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52701882 |
138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.52468246 |
139 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52338758 |
140 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51264625 |
141 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50651994 |
142 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49687891 |
143 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48404840 |
144 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.46872927 |
145 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46496411 |
146 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44765324 |
147 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44712968 |
148 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44471636 |
149 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.43860766 |
150 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.43642175 |
151 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42993219 |
152 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42494008 |
153 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41039471 |
154 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40292848 |
155 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.39941059 |
156 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.39700508 |
157 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.39414215 |
158 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.39247106 |
159 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39241377 |
160 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39164478 |
161 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.38156460 |
162 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.38053193 |
163 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.37829373 |
164 | NCOR_22424771_ChIP-Seq_293T_Human | 0.37518361 |
165 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.37061699 |
166 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.36848840 |
167 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.36312616 |
168 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.36148073 |
169 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.36092511 |
170 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.35256664 |
171 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.35077419 |
172 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.35072522 |
173 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34971565 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.41092035 |
2 | MP0005360_urolithiasis | 7.62468864 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.54820154 |
4 | MP0005365_abnormal_bile_salt | 6.14428197 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.52627013 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.04194878 |
7 | MP0003252_abnormal_bile_duct | 3.89775407 |
8 | MP0010329_abnormal_lipoprotein_level | 3.54335242 |
9 | MP0009840_abnormal_foam_cell | 3.19052795 |
10 | MP0005083_abnormal_biliary_tract | 3.06005888 |
11 | MP0003195_calcinosis | 2.89655062 |
12 | MP0005332_abnormal_amino_acid | 2.80779214 |
13 | MP0001666_abnormal_nutrient_absorption | 2.57231542 |
14 | MP0003879_abnormal_hair_cell | 2.50667737 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.16207304 |
16 | MP0005551_abnormal_eye_electrophysiolog | 2.15393944 |
17 | MP0001984_abnormal_olfaction | 2.12882209 |
18 | MP0000609_abnormal_liver_physiology | 2.12022484 |
19 | MP0003191_abnormal_cellular_cholesterol | 2.11399671 |
20 | MP0008877_abnormal_DNA_methylation | 2.11112824 |
21 | MP0002118_abnormal_lipid_homeostasis | 2.10505549 |
22 | MP0002102_abnormal_ear_morphology | 2.08206799 |
23 | MP0002653_abnormal_ependyma_morphology | 2.08131927 |
24 | MP0009046_muscle_twitch | 2.04166989 |
25 | MP0003868_abnormal_feces_composition | 1.95083395 |
26 | MP0002138_abnormal_hepatobiliary_system | 1.89788335 |
27 | MP0005319_abnormal_enzyme/_coenzyme | 1.81944221 |
28 | MP0006292_abnormal_olfactory_placode | 1.73228619 |
29 | MP0001486_abnormal_startle_reflex | 1.67938607 |
30 | MP0001764_abnormal_homeostasis | 1.67481255 |
31 | MP0005377_hearing/vestibular/ear_phenot | 1.67198658 |
32 | MP0003878_abnormal_ear_physiology | 1.67198658 |
33 | MP0009745_abnormal_behavioral_response | 1.63540804 |
34 | MP0003880_abnormal_central_pattern | 1.58283500 |
35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56753384 |
36 | MP0009697_abnormal_copulation | 1.55836917 |
37 | MP0003183_abnormal_peptide_metabolism | 1.53641385 |
38 | MP0001968_abnormal_touch/_nociception | 1.49915017 |
39 | MP0003136_yellow_coat_color | 1.48779881 |
40 | MP0002064_seizures | 1.45972566 |
41 | MP0002272_abnormal_nervous_system | 1.41782186 |
42 | MP0005451_abnormal_body_composition | 1.39291771 |
43 | MP0001986_abnormal_taste_sensitivity | 1.36055528 |
44 | MP0001501_abnormal_sleep_pattern | 1.31057679 |
45 | MP0002735_abnormal_chemical_nociception | 1.29301170 |
46 | MP0003011_delayed_dark_adaptation | 1.26172521 |
47 | MP0001485_abnormal_pinna_reflex | 1.25517999 |
48 | MP0003656_abnormal_erythrocyte_physiolo | 1.24160366 |
49 | MP0009780_abnormal_chondrocyte_physiolo | 1.22803766 |
50 | MP0009643_abnormal_urine_homeostasis | 1.22627347 |
51 | MP0003186_abnormal_redox_activity | 1.19988754 |
52 | MP0002736_abnormal_nociception_after | 1.19567989 |
53 | MP0005423_abnormal_somatic_nervous | 1.19290096 |
54 | MP0003635_abnormal_synaptic_transmissio | 1.18233594 |
55 | MP0000598_abnormal_liver_morphology | 1.14870633 |
56 | MP0004859_abnormal_synaptic_plasticity | 1.14356675 |
57 | MP0004142_abnormal_muscle_tone | 1.12275102 |
58 | MP0002572_abnormal_emotion/affect_behav | 1.11775290 |
59 | MP0005647_abnormal_sex_gland | 1.09834355 |
60 | MP0000604_amyloidosis | 1.07347217 |
61 | MP0005646_abnormal_pituitary_gland | 1.06587986 |
62 | MP0002063_abnormal_learning/memory/cond | 1.04413528 |
63 | MP0009764_decreased_sensitivity_to | 1.03867192 |
64 | MP0004043_abnormal_pH_regulation | 1.03635290 |
65 | MP0003705_abnormal_hypodermis_morpholog | 1.03188363 |
66 | MP0003633_abnormal_nervous_system | 1.02587534 |
67 | MP0004270_analgesia | 1.00764395 |
68 | MP0005670_abnormal_white_adipose | 1.00406883 |
69 | MP0009763_increased_sensitivity_to | 0.98893081 |
70 | MP0002254_reproductive_system_inflammat | 0.97604017 |
71 | MP0006072_abnormal_retinal_apoptosis | 0.97077433 |
72 | MP0005386_behavior/neurological_phenoty | 0.93631605 |
73 | MP0004924_abnormal_behavior | 0.93631605 |
74 | MP0005253_abnormal_eye_physiology | 0.92954484 |
75 | MP0002132_abnormal_respiratory_system | 0.90882042 |
76 | MP0005636_abnormal_mineral_homeostasis | 0.90418279 |
77 | MP0010368_abnormal_lymphatic_system | 0.89403111 |
78 | MP0005410_abnormal_fertilization | 0.88790199 |
79 | MP0002067_abnormal_sensory_capabilities | 0.87666472 |
80 | MP0004742_abnormal_vestibular_system | 0.86644183 |
81 | MP0009642_abnormal_blood_homeostasis | 0.86234382 |
82 | MP0008057_abnormal_DNA_replication | 0.85103930 |
83 | MP0002229_neurodegeneration | 0.85037475 |
84 | MP0001963_abnormal_hearing_physiology | 0.84386115 |
85 | MP0008469_abnormal_protein_level | 0.84253486 |
86 | MP0002876_abnormal_thyroid_physiology | 0.83351129 |
87 | MP0005408_hypopigmentation | 0.81520123 |
88 | MP0006036_abnormal_mitochondrial_physio | 0.81255511 |
89 | MP0005084_abnormal_gallbladder_morpholo | 0.80420564 |
90 | MP0006276_abnormal_autonomic_nervous | 0.79832539 |
91 | MP0009765_abnormal_xenobiotic_induced | 0.79668726 |
92 | MP0002078_abnormal_glucose_homeostasis | 0.79489688 |
93 | MP0005376_homeostasis/metabolism_phenot | 0.78330700 |
94 | MP0002557_abnormal_social/conspecific_i | 0.76645555 |
95 | MP0003631_nervous_system_phenotype | 0.76010593 |
96 | MP0004130_abnormal_muscle_cell | 0.75425159 |
97 | MP0003698_abnormal_male_reproductive | 0.75097639 |
98 | MP0005535_abnormal_body_temperature | 0.74944802 |
99 | MP0001502_abnormal_circadian_rhythm | 0.74038510 |
100 | MP0003329_amyloid_beta_deposits | 0.73659944 |
101 | MP0003690_abnormal_glial_cell | 0.73139674 |
102 | MP0001440_abnormal_grooming_behavior | 0.72755944 |
103 | MP0002971_abnormal_brown_adipose | 0.72403914 |
104 | MP0002734_abnormal_mechanical_nocicepti | 0.70003534 |
105 | MP0005334_abnormal_fat_pad | 0.69337285 |
106 | MP0005220_abnormal_exocrine_pancreas | 0.68849039 |
107 | MP0010386_abnormal_urinary_bladder | 0.67036914 |
108 | MP0004885_abnormal_endolymph | 0.66120552 |
109 | MP0002822_catalepsy | 0.65864300 |
110 | MP0005266_abnormal_metabolism | 0.63982559 |
111 | MP0001661_extended_life_span | 0.63780008 |
112 | MP0003632_abnormal_nervous_system | 0.63254470 |
113 | MP0001970_abnormal_pain_threshold | 0.62003202 |
114 | MP0000639_abnormal_adrenal_gland | 0.60021413 |
115 | MP0001756_abnormal_urination | 0.58896461 |
116 | MP0000569_abnormal_digit_pigmentation | 0.58607384 |
117 | MP0009053_abnormal_anal_canal | 0.58564233 |
118 | MP0002160_abnormal_reproductive_system | 0.57426505 |
119 | MP0008874_decreased_physiological_sensi | 0.56958207 |
120 | MP0005448_abnormal_energy_balance | 0.56473327 |
121 | MP0006035_abnormal_mitochondrial_morpho | 0.54373103 |
122 | MP0008872_abnormal_physiological_respon | 0.52755747 |
123 | MP0003638_abnormal_response/metabolism_ | 0.50284840 |
124 | MP0002837_dystrophic_cardiac_calcinosis | 0.49812877 |
125 | MP0008873_increased_physiological_sensi | 0.46100230 |
126 | MP0005464_abnormal_platelet_physiology | 0.45937149 |
127 | MP0005395_other_phenotype | 0.44738392 |
128 | MP0002928_abnormal_bile_duct | 0.44175457 |
129 | MP0004782_abnormal_surfactant_physiolog | 0.43649969 |
130 | MP0002136_abnormal_kidney_physiology | 0.42826745 |
131 | MP0003075_altered_response_to | 0.42796747 |
132 | MP0003953_abnormal_hormone_level | 0.42730860 |
133 | MP0003718_maternal_effect | 0.41456594 |
134 | MP0005248_abnormal_Harderian_gland | 0.40494496 |
135 | MP0005666_abnormal_adipose_tissue | 0.39616783 |
136 | MP0009672_abnormal_birth_weight | 0.38410208 |
137 | MP0005166_decreased_susceptibility_to | 0.36131556 |
138 | MP0000579_abnormal_nail_morphology | 0.35567662 |
139 | MP0003724_increased_susceptibility_to | 0.35439542 |
140 | MP0000230_abnormal_systemic_arterial | 0.33758177 |
141 | MP0002090_abnormal_vision | 0.33576136 |
142 | MP0003436_decreased_susceptibility_to | 0.32524865 |
143 | MP0009115_abnormal_fat_cell | 0.31652815 |
144 | MP0002168_other_aberrant_phenotype | 0.30877043 |
145 | MP0004883_abnormal_blood_vessel | 0.29234886 |
146 | MP0002970_abnormal_white_adipose | 0.28912934 |
147 | MP0000249_abnormal_blood_vessel | 0.28724248 |
148 | MP0001243_abnormal_dermal_layer | 0.28397219 |
149 | MP0009384_cardiac_valve_regurgitation | 0.27913984 |
150 | MP0001881_abnormal_mammary_gland | 0.27562629 |
151 | MP0001853_heart_inflammation | 0.26406067 |
152 | MP0005167_abnormal_blood-brain_barrier | 0.24791348 |
153 | MP0004381_abnormal_hair_follicle | 0.24667493 |
154 | MP0002796_impaired_skin_barrier | 0.23670688 |
155 | MP0001845_abnormal_inflammatory_respons | 0.21866014 |
156 | MP0005058_abnormal_lysosome_morphology | 0.21392576 |
157 | MP0005187_abnormal_penis_morphology | 0.20897434 |
158 | MP0005164_abnormal_response_to | 0.20296201 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.66570157 |
2 | Deep venous thrombosis (HP:0002625) | 7.45759679 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.21341023 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.82041848 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.61452603 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.39189014 |
7 | Xanthomatosis (HP:0000991) | 6.23642149 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.62291063 |
9 | Complement deficiency (HP:0004431) | 5.20394901 |
10 | Hypolipoproteinemia (HP:0010981) | 4.75459656 |
11 | Joint hemorrhage (HP:0005261) | 4.75005627 |
12 | Hyperammonemia (HP:0001987) | 4.64069102 |
13 | Epidermoid cyst (HP:0200040) | 4.57995427 |
14 | Abnormality of methionine metabolism (HP:0010901) | 4.38968185 |
15 | Ketosis (HP:0001946) | 4.38663765 |
16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.35957569 |
17 | Hyperglycinemia (HP:0002154) | 4.35307343 |
18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.32222333 |
19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.28643042 |
20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.25903955 |
21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.20583212 |
22 | Hypoalphalipoproteinemia (HP:0003233) | 4.16203299 |
23 | Fat malabsorption (HP:0002630) | 4.01601664 |
24 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.99155475 |
25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.96318084 |
26 | Hyperglycinuria (HP:0003108) | 3.91861556 |
27 | Abnormality of glycine metabolism (HP:0010895) | 3.90429511 |
28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90429511 |
29 | Hypoglycemic coma (HP:0001325) | 3.79571118 |
30 | Abnormality of complement system (HP:0005339) | 3.76907204 |
31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.75038030 |
32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74716081 |
33 | Hypercholesterolemia (HP:0003124) | 3.73727698 |
34 | Hyperbilirubinemia (HP:0002904) | 3.36547605 |
35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34322391 |
36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.27154734 |
37 | Delayed CNS myelination (HP:0002188) | 3.19067490 |
38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.11693978 |
39 | Fair hair (HP:0002286) | 3.09678895 |
40 | Abnormality of serum amino acid levels (HP:0003112) | 3.09047903 |
41 | Ketoacidosis (HP:0001993) | 3.06813211 |
42 | Steatorrhea (HP:0002570) | 3.03303715 |
43 | Myocardial infarction (HP:0001658) | 2.92107383 |
44 | Hepatocellular carcinoma (HP:0001402) | 2.91042302 |
45 | Skin nodule (HP:0200036) | 2.85072836 |
46 | Spontaneous abortion (HP:0005268) | 2.83856612 |
47 | Hypochromic microcytic anemia (HP:0004840) | 2.83120571 |
48 | Focal motor seizures (HP:0011153) | 2.76797457 |
49 | Metabolic acidosis (HP:0001942) | 2.74942734 |
50 | Abnormality of purine metabolism (HP:0004352) | 2.69381926 |
51 | Systemic lupus erythematosus (HP:0002725) | 2.66346600 |
52 | Lethargy (HP:0001254) | 2.63198673 |
53 | Vascular calcification (HP:0004934) | 2.60435207 |
54 | Osteomalacia (HP:0002749) | 2.60090771 |
55 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.56352196 |
56 | Cerebral edema (HP:0002181) | 2.53245154 |
57 | Dicarboxylic aciduria (HP:0003215) | 2.51057240 |
58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51057240 |
59 | Abnormal gallbladder morphology (HP:0012437) | 2.50221284 |
60 | Mitral stenosis (HP:0001718) | 2.50185987 |
61 | Hypoglycemic seizures (HP:0002173) | 2.49522194 |
62 | Acanthocytosis (HP:0001927) | 2.48541147 |
63 | Spastic diplegia (HP:0001264) | 2.48102228 |
64 | Pigmentary retinal degeneration (HP:0001146) | 2.47442050 |
65 | Irritability (HP:0000737) | 2.45193608 |
66 | Gout (HP:0001997) | 2.44244330 |
67 | Cholelithiasis (HP:0001081) | 2.42314034 |
68 | Focal seizures (HP:0007359) | 2.42248370 |
69 | Neonatal onset (HP:0003623) | 2.41689188 |
70 | Glomerulonephritis (HP:0000099) | 2.41597298 |
71 | Hypomagnesemia (HP:0002917) | 2.38856903 |
72 | Polydipsia (HP:0001959) | 2.37158614 |
73 | Abnormal drinking behavior (HP:0030082) | 2.37158614 |
74 | Atonic seizures (HP:0010819) | 2.37089333 |
75 | Cholecystitis (HP:0001082) | 2.35578800 |
76 | Abnormal gallbladder physiology (HP:0012438) | 2.35578800 |
77 | Gaze-evoked nystagmus (HP:0000640) | 2.30691239 |
78 | Cardiovascular calcification (HP:0011915) | 2.30516928 |
79 | Rhinitis (HP:0012384) | 2.30120386 |
80 | Increased circulating renin level (HP:0000848) | 2.28572601 |
81 | Polyuria (HP:0000103) | 2.28566244 |
82 | Cerebral hypomyelination (HP:0006808) | 2.26509136 |
83 | Nephritis (HP:0000123) | 2.26182900 |
84 | Chronic bronchitis (HP:0004469) | 2.24208010 |
85 | Hyperventilation (HP:0002883) | 2.23411511 |
86 | Febrile seizures (HP:0002373) | 2.21328521 |
87 | Abnormal urine output (HP:0012590) | 2.20236381 |
88 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19594538 |
89 | Brushfield spots (HP:0001088) | 2.19425984 |
90 | Myokymia (HP:0002411) | 2.18689920 |
91 | Amyloidosis (HP:0011034) | 2.18252243 |
92 | Progressive cerebellar ataxia (HP:0002073) | 2.16563039 |
93 | Late onset (HP:0003584) | 2.14118790 |
94 | Menorrhagia (HP:0000132) | 2.13481580 |
95 | Sensorimotor neuropathy (HP:0007141) | 2.11853679 |
96 | Generalized hypopigmentation of hair (HP:0011358) | 2.11211078 |
97 | Esophageal varix (HP:0002040) | 2.10003043 |
98 | Malnutrition (HP:0004395) | 2.09688800 |
99 | Epileptic encephalopathy (HP:0200134) | 2.08656606 |
100 | Pancreatitis (HP:0001733) | 2.08363300 |
101 | Enlarged kidneys (HP:0000105) | 2.08117653 |
102 | Metabolic alkalosis (HP:0200114) | 2.06453109 |
103 | Vomiting (HP:0002013) | 2.06401504 |
104 | Absence seizures (HP:0002121) | 2.06285204 |
105 | Attenuation of retinal blood vessels (HP:0007843) | 2.05681961 |
106 | Gingival bleeding (HP:0000225) | 2.04544754 |
107 | Poikilocytosis (HP:0004447) | 2.03409098 |
108 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03006047 |
109 | Abnormality of the gallbladder (HP:0005264) | 2.01828240 |
110 | Opisthotonus (HP:0002179) | 2.01385095 |
111 | Pancreatic cysts (HP:0001737) | 1.99861088 |
112 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.98837649 |
113 | Abnormality of alanine metabolism (HP:0010916) | 1.98837649 |
114 | Hyperalaninemia (HP:0003348) | 1.98837649 |
115 | Hemiparesis (HP:0001269) | 1.98486131 |
116 | Generalized aminoaciduria (HP:0002909) | 1.98097969 |
117 | Status epilepticus (HP:0002133) | 1.97969134 |
118 | Thrombophlebitis (HP:0004418) | 1.96463532 |
119 | Hemorrhage of the eye (HP:0011885) | 1.96407506 |
120 | Alkalosis (HP:0001948) | 1.94834661 |
121 | Agammaglobulinemia (HP:0004432) | 1.94293005 |
122 | Occipital encephalocele (HP:0002085) | 1.93107043 |
123 | Hypophosphatemic rickets (HP:0004912) | 1.92771513 |
124 | Nephrogenic diabetes insipidus (HP:0009806) | 1.92547385 |
125 | Rickets (HP:0002748) | 1.91895164 |
126 | True hermaphroditism (HP:0010459) | 1.91154857 |
127 | Hydroxyprolinuria (HP:0003080) | 1.90479889 |
128 | Abnormality of proline metabolism (HP:0010907) | 1.90479889 |
129 | Hypokalemic alkalosis (HP:0001949) | 1.90103244 |
130 | Medial flaring of the eyebrow (HP:0010747) | 1.89990783 |
131 | Dialeptic seizures (HP:0011146) | 1.88709283 |
132 | Bile duct proliferation (HP:0001408) | 1.88055380 |
133 | Abnormal biliary tract physiology (HP:0012439) | 1.88055380 |
134 | Abnormal cartilage morphology (HP:0002763) | 1.86879984 |
135 | Gait imbalance (HP:0002141) | 1.86750983 |
136 | Hyperglycemia (HP:0003074) | 1.85661677 |
137 | Abnormality of iron homeostasis (HP:0011031) | 1.84410100 |
138 | Abnormality of renal excretion (HP:0011036) | 1.82537321 |
139 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81484616 |
140 | Chronic hepatic failure (HP:0100626) | 1.81103261 |
141 | Renal cortical cysts (HP:0000803) | 1.79519997 |
142 | Thyroiditis (HP:0100646) | 1.79443944 |
143 | Reticulocytosis (HP:0001923) | 1.77796821 |
144 | Absent speech (HP:0001344) | 1.77631517 |
145 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77571366 |
146 | Generalized tonic-clonic seizures (HP:0002069) | 1.77159799 |
147 | Elevated hepatic transaminases (HP:0002910) | 1.75651293 |
148 | Pancreatic fibrosis (HP:0100732) | 1.74830591 |
149 | Delayed myelination (HP:0012448) | 1.74024784 |
150 | Congenital primary aphakia (HP:0007707) | 1.73960290 |
151 | Acute hepatic failure (HP:0006554) | 1.73562194 |
152 | Hyperaldosteronism (HP:0000859) | 1.73548226 |
153 | Neonatal hypoglycemia (HP:0001998) | 1.72633193 |
154 | Abolished electroretinogram (ERG) (HP:0000550) | 1.72216130 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.15475072 |
2 | SIK1 | 4.68747489 |
3 | FGFR4 | 4.36623502 |
4 | ERN1 | 3.84761552 |
5 | WNK3 | 3.65296012 |
6 | INSRR | 3.18697470 |
7 | TAOK3 | 2.94443809 |
8 | ERBB4 | 2.92593795 |
9 | NTRK3 | 2.87059677 |
10 | MAP2K4 | 2.70759133 |
11 | PKN2 | 2.41482491 |
12 | MAP4K2 | 2.34416802 |
13 | PNCK | 2.30754778 |
14 | CAMKK2 | 2.14669512 |
15 | MST1R | 2.10539982 |
16 | KIT | 2.09348404 |
17 | FLT3 | 1.91073642 |
18 | ACVR1B | 1.89149341 |
19 | MAPK11 | 1.84891709 |
20 | OXSR1 | 1.79254140 |
21 | DAPK2 | 1.78377178 |
22 | TRIB3 | 1.65974191 |
23 | PIK3CG | 1.62432908 |
24 | TNK2 | 1.54837580 |
25 | ABL2 | 1.51692156 |
26 | TYK2 | 1.50978390 |
27 | MARK1 | 1.48521742 |
28 | BMPR1B | 1.48010293 |
29 | LATS1 | 1.47936769 |
30 | FGFR2 | 1.47062479 |
31 | MAPK13 | 1.44186598 |
32 | CASK | 1.38699289 |
33 | NUAK1 | 1.38654189 |
34 | SIK2 | 1.37520877 |
35 | FRK | 1.34951520 |
36 | PTK6 | 1.34474339 |
37 | PINK1 | 1.28554411 |
38 | MAP3K7 | 1.28295005 |
39 | JAK2 | 1.23716290 |
40 | EPHA4 | 1.22591911 |
41 | KDR | 1.15343075 |
42 | NEK9 | 1.13708099 |
43 | PRKAA2 | 1.13209333 |
44 | GRK6 | 1.11125478 |
45 | ADRBK2 | 1.08936847 |
46 | NTRK2 | 1.08765479 |
47 | ARAF | 1.07497072 |
48 | STK38 | 1.06959199 |
49 | TXK | 1.05478502 |
50 | ERBB2 | 1.03312749 |
51 | MAPK4 | 1.03190619 |
52 | PRKCE | 1.02848381 |
53 | PRKCZ | 1.02530239 |
54 | ZAK | 1.02298808 |
55 | MAPKAPK3 | 1.01657049 |
56 | JAK1 | 0.97550482 |
57 | PLK2 | 0.97227677 |
58 | MAP2K3 | 0.95379612 |
59 | MAP3K14 | 0.92439915 |
60 | TNIK | 0.92252658 |
61 | TBK1 | 0.92087834 |
62 | CAMK1 | 0.90418498 |
63 | MAPK12 | 0.88568513 |
64 | CDK19 | 0.88229566 |
65 | TIE1 | 0.86160428 |
66 | CAMK2A | 0.86139780 |
67 | PTK2B | 0.85377765 |
68 | DYRK1A | 0.84107357 |
69 | CAMK2G | 0.82947340 |
70 | MINK1 | 0.81492586 |
71 | DAPK1 | 0.80181110 |
72 | PRKACG | 0.79801417 |
73 | MAP2K6 | 0.79331965 |
74 | MET | 0.79222264 |
75 | MAP3K12 | 0.76023675 |
76 | STK38L | 0.75443449 |
77 | SGK3 | 0.73500624 |
78 | MAP3K10 | 0.72500575 |
79 | PDK2 | 0.72393718 |
80 | MAPK15 | 0.72188358 |
81 | MAP3K13 | 0.71888775 |
82 | GRK7 | 0.71820662 |
83 | MAP3K3 | 0.69855868 |
84 | MAP3K11 | 0.69804917 |
85 | CDK6 | 0.68890321 |
86 | PRKACA | 0.68535930 |
87 | CSK | 0.68293842 |
88 | CAMK2D | 0.68216557 |
89 | CAMK1D | 0.68140882 |
90 | DYRK2 | 0.67320508 |
91 | STK3 | 0.67176486 |
92 | FER | 0.66959199 |
93 | EPHB1 | 0.66894854 |
94 | PRKAA1 | 0.65074745 |
95 | CDK5 | 0.64730494 |
96 | MAPK7 | 0.62448987 |
97 | SGK1 | 0.61782882 |
98 | GSK3A | 0.61350541 |
99 | EPHA3 | 0.61315550 |
100 | DYRK1B | 0.60852944 |
101 | CSNK1D | 0.60747613 |
102 | RET | 0.60384038 |
103 | PDPK1 | 0.60258243 |
104 | BCR | 0.60184397 |
105 | RAF1 | 0.59970438 |
106 | PRKG1 | 0.58457944 |
107 | RIPK1 | 0.57659130 |
108 | SGK2 | 0.56844663 |
109 | PAK6 | 0.56844627 |
110 | PRKCG | 0.56629073 |
111 | TAOK2 | 0.55947679 |
112 | CSNK1A1 | 0.55906703 |
113 | ADRBK1 | 0.55551071 |
114 | CAMK2B | 0.54552381 |
115 | RPS6KA3 | 0.53924714 |
116 | PRKCQ | 0.53650478 |
117 | PTK2 | 0.53343890 |
118 | NLK | 0.52679419 |
119 | PHKG2 | 0.52255705 |
120 | PHKG1 | 0.52255705 |
121 | FGFR3 | 0.51951207 |
122 | CSNK1G1 | 0.51572704 |
123 | CDK3 | 0.50317924 |
124 | TEC | 0.50271034 |
125 | MAP2K1 | 0.50250354 |
126 | MAP3K5 | 0.47805270 |
127 | IKBKE | 0.47717307 |
128 | PRKACB | 0.47399530 |
129 | MAP3K9 | 0.47311751 |
130 | SYK | 0.46464926 |
131 | IGF1R | 0.45758309 |
132 | EIF2AK3 | 0.45627991 |
133 | PRKCB | 0.45573293 |
134 | BMPR2 | 0.44858786 |
135 | SGK494 | 0.43971628 |
136 | SGK223 | 0.43971628 |
137 | TGFBR2 | 0.43743396 |
138 | PKN1 | 0.43162508 |
139 | PDK1 | 0.42928367 |
140 | CSF1R | 0.42639976 |
141 | CSNK1G2 | 0.42142469 |
142 | IRAK3 | 0.40042325 |
143 | ICK | 0.38818859 |
144 | GRK1 | 0.38802320 |
145 | MAP3K6 | 0.38659549 |
146 | MAP3K1 | 0.37774632 |
147 | LATS2 | 0.35889106 |
148 | MAP3K4 | 0.35761411 |
149 | EGFR | 0.35564068 |
150 | CAMK4 | 0.34667523 |
151 | MAP3K2 | 0.33699534 |
152 | PRKCA | 0.32615685 |
153 | PIK3CA | 0.32547909 |
154 | IRAK2 | 0.32337495 |
155 | PAK3 | 0.32291458 |
156 | CAMKK1 | 0.31070154 |
157 | CSNK1G3 | 0.29806327 |
158 | CAMK1G | 0.29798694 |
159 | KSR2 | 0.28848803 |
160 | PDK3 | 0.27959740 |
161 | PDK4 | 0.27959740 |
162 | MTOR | 0.26349737 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.50421701 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.61939285 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.52695411 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44060112 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.15321965 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.74083678 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67839411 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.66822297 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54996275 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50060315 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41324529 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34020331 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32084193 |
14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.22921993 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13785500 |
16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.04677461 |
17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.04298902 |
18 | Peroxisome_Homo sapiens_hsa04146 | 2.03769054 |
19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.02619249 |
20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.00942791 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91307409 |
22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88914252 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84038682 |
24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.79346799 |
25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73668226 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73232770 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69154741 |
28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68499461 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65569046 |
30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60895261 |
31 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60477202 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55064815 |
33 | Bile secretion_Homo sapiens_hsa04976 | 1.54434961 |
34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52976344 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52135028 |
36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51660754 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42866474 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35851828 |
39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31552265 |
40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31391680 |
41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30948401 |
42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23265092 |
43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21160785 |
44 | ABC transporters_Homo sapiens_hsa02010 | 1.20726395 |
45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15601238 |
46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15535971 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10845290 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09414084 |
49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02765727 |
50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00153120 |
51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97080584 |
52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95528657 |
53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94909665 |
54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92631524 |
55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87012297 |
56 | Nicotine addiction_Homo sapiens_hsa05033 | 0.83738250 |
57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83337668 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83316365 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.78216167 |
60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77840031 |
61 | Phototransduction_Homo sapiens_hsa04744 | 0.75013500 |
62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69057135 |
63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67848481 |
64 | GABAergic synapse_Homo sapiens_hsa04727 | 0.65555957 |
65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65296673 |
66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61398074 |
67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61055503 |
68 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.58432480 |
69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51922468 |
70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49828785 |
71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49212320 |
72 | Insulin secretion_Homo sapiens_hsa04911 | 0.48743082 |
73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.46509844 |
74 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45662351 |
75 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.44196418 |
76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39376146 |
77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37476532 |
78 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.37339614 |
79 | Taste transduction_Homo sapiens_hsa04742 | 0.35404856 |
80 | Morphine addiction_Homo sapiens_hsa05032 | 0.33205780 |
81 | Prion diseases_Homo sapiens_hsa05020 | 0.33109740 |
82 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32884947 |
83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29572579 |
84 | Salivary secretion_Homo sapiens_hsa04970 | 0.24579562 |
85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23802909 |
86 | Insulin resistance_Homo sapiens_hsa04931 | 0.23087968 |
87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22135772 |
88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21648892 |
89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21301758 |
90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.20778661 |
91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20666806 |
92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.16965639 |
93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.16335373 |
94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16113976 |
95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.15964957 |
96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.14702715 |
97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14374311 |
98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14182923 |
99 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.14178882 |
100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.13358105 |
101 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.12813375 |
102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.09510139 |
103 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.09301033 |
104 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.08873391 |
105 | Long-term depression_Homo sapiens_hsa04730 | 0.08342432 |
106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.08153014 |
107 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.08139002 |
108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03221999 |
109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2375494 |
110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2321227 |
111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2285432 |
112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2172255 |
113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2170705 |
114 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2157872 |
115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2113463 |
116 | Hepatitis C_Homo sapiens_hsa05160 | -0.2084601 |
117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.2032657 |
118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1906649 |
119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1649042 |
120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1612773 |
121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1548571 |
122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1526614 |
123 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1365599 |
124 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1304867 |
125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1236697 |
126 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0827484 |
127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0593138 |
128 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0380856 |
129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0281915 |